Secondary
Metabolite screening, Bioactive compound extraction, and Disrupting Mitotic
Activity of Wild Cabbage [Brassicaceae] towards Cancer
Management.
A. Thenmozhi1, Dr. U.S Mahadeva Rao2*
ABSTRACT:
Objective: The present study has
been formulated with an objective to establish the preliminary phytochemical
analysis and antimitotic activity of Brassica oleracea. Method: Brassica oleracea was collected,
homogenized and extracted with different solvents. Antimitotic
activity of Brassica oleracea
was evaluated using the meristamatic cells from the
root of Allium cepa.
Experiments were carried out with incorporation of folic acid in the extract.
Results: The preliminary study revealed the presence of flavonoids,
steroids, alkaloids, saponins, polyphenols
and glycosides. Folic acid inhibited the antimitotic
activity of Brassica oleracea
extract. The antimitotic activity obtained was
compared with methotrexate-a referred anticancer
drug. Discussion: The results obtained from the present study pinpoint that antimitotic activity of Brassica oleracea may be due to the presence of flavonoids,
steroids, alkaloids, polyphenols and saponins. Conclusion: Hence Brassica
oleracea is a promising source of phytochemicals
which promote human health by strengthening the human immune system, inactivate
cancer-causing substances, protect the heart and eyes from disease, boost
enzyme activity to increase the benefits of the various protective enzymes,
reduce bad cholesterol levels, and anti-aging.
KEYWORDS: Antimitotic; Brassica oleracea;
Allium cepa; Polyphenols; Saponins.
INTRODUCTION:
The
functional food industry has produced and marketed foods enriched with
bioactive compounds, but there are no universally accepted criteria for judging
efficacy of the compounds or enriched foods. The lack of understanding
bioactive compounds and their health benefits should not serve to reduce research
interest but should instead encourage plant and nutritional scientists to work
together to develop strategies for improvement of health through food1.
Cruciferous vegetables are an excellent dietary source
of phytochemicals including glucosinolates
(and glucosinolate breakdown products), phenolics and other antioxidants like vitamins(C, K1,
etc.), as well as dietary essential minerals (Ca, Mg, Na, K, Fe, Zn, etc.).
Dietary antioxidants (i.e. vitamins, flavonoids)
present in broccoli may decrease the risk of certain cancers2.
Broccoli is a plant of the cabbage family Brassicaceae (formerly
Cruciferae). It is classified in the Italica cultivar group of the species Brassica
oleracea. Broccoli has large flower heads,
usually green in color, arranged in a tree-like fashion on branches sprouting
from a thick, edible stalk. The mass of flower heads is surrounded by leaves.
Broccoli most closely resembles cauliflower, which is a different cultivar
group of the same species3.
Research on Brassica vegetables has been focused on the edible parts.
However, scarce information is available regardingthe
corresponding by-products, which are in fact a good source of phenolic compounds of this unusual food product (i.e.
cauliflower leaf as by-product) with possible uses as a dietary or food
antioxidant4.
The
cancer-protective properties of Brassica (i.e. broccoli) consumption are most likely
mediated through bioactive compounds that induce a variety of physiological
functions including acting as direct or indirect antioxidants, regulating
enzymes and controlling apoptosis and the cell cycle.
The antimitotic activity was
screened using Allium cepa root meristamatic cells which have been used extensively in
screening of drugs with antimitotic activity5,6.
The roots of all plants have distinguished regions, one of them being the
region of cell division that lies beyond the root cap and extends a few
millimeters after that. Cells of this region undergo repeated divisions. The
fate of cell division is higher in this region compared to that of the other
tissues. This region is called the meristamatic
region (meristos: divided)7. This division is similar to the above mentioned
cancer division in humans. Hence, these meristamatic
cells can be used for preliminary screening of drugs with anticancer activity.
Even though doubts can be raised about extrapolation of results from plant tissue
to animals and finally to humans, Khilman has noted
that plant cells are 1000 times more resistant to colchicines which is a potent
anti-carcinogen and which acts by inhibiting the microtubule formation. Thus,
it is possible that chemicals that affect plant chromosomes will also affect
animals8.
The American Cancer Society recommends eating more
broccoli and other cruciferous vegetables because they contain anti-cancer phytochemicals. The American government has been endowing a
number of research projects aimed at exploring Brassica oleracea facts and the potential of
using Brassica oleracea to
reduce cancers and other degenerative diseases. Brassica oleracea facts and nutrition information
explains that this plant is one of the most important vegetable in the world
because of its cancer fighting ability.
MATERIALS
AND METHODS:
Collection of plant material:
The Brassica oleracea were purchased from Reliance Fresh, Chennai.
Botanical identification was made from Herbarium of Department of Plant Biotechnology,
Pachaiyappa's college, Chennai and voucher specimen
was submitted in the herbarium. Fresh floret and stem were homogenized with
solvents and then extracted. Allium cepa bulbs (red
variety) were purchased from the local market and stored for the entire study.
Carmine stain was procured from Sigma Aldrich, Bangalore. Other solvents used
for extraction were of LR grade and were distilled before use for greater
purity.
Preparation of extracts:
The floret and stem (3g each) were homogenized with
solvents. The sample was kept in shaker for 30 minutes to get the aqueous
extract. The extract obtained was concentrated and dried under controlled
temperature (600C). The dried powder was successively extracted with
other solvents ethanol, methanol, Chloroform, and petroleum ether. Finally it
was concentrated and made up to particular volume. Extraction with each solvent
was done in a water bath for 60 minutes with a reflux condenser. Each time
before extracting with the next solvent the marc was dried in an air oven below
50oC. Each extract was concentrated and evaporated to dry extract.
Extracts of desired concentrations were prepared for further study using these
dried extracts.
Table.1: Qualitative Analysis of the phytochemicals of aqueous and organic extracts of Brassica oleracea
S. No |
Phytochemical tests |
Methanol |
Petroleum ether |
Aqueous |
Chloroform |
Ice cold water |
Ethanol |
||||||
Floret |
Stem |
Floret |
Stem |
Floret |
Stem |
Floret |
Stem |
Floret |
Stem |
Floret |
Stem |
||
1 |
Flavanoids |
+++ |
+++ |
+++ |
+++ |
+++ |
+++ |
+++ |
+++ |
+++ |
+++ |
+++ |
+++ |
2 |
Steriod (Salkowski) |
+++ |
++ |
+++ |
++ |
+++ |
++ |
+++ |
++ |
+++ |
++ |
+++ |
++ |
3 |
Steriod (Libermanns) |
++ |
+ |
++ |
+ |
++ |
- - |
+++ |
+++ |
+++ |
+++ |
+++ |
++ |
4 |
Alkaloids (Ehrlich s) |
- - - |
- - - |
- - - |
- - - |
- - - |
- - - |
- - - |
- - - |
- - - |
- - - |
- - - |
- - - |
5 |
Alkaloids (Mayers) |
+++ |
++ |
+++ |
++ |
+++ |
++ |
+++ |
++ |
+++ |
++ |
+++ |
++ |
6 |
Saponins (froth) |
+++ |
+++ |
- - - |
- - - |
+++ |
+++ |
- - - |
- - - |
+++ |
+++ |
- - - |
- - - |
7 |
Tannins |
- - - |
- - - |
- - - |
- - - |
- |
- |
- |
- |
- |
- |
- |
- |
8 |
Phenol(Ferric chloride) |
- - - |
- - - |
- - - |
- - - |
- - - |
- - - |
- - - |
- - - |
- - - |
- - - |
- - - |
- - - |
9 |
Phenol (Lead acetate) |
+++ |
++ |
++ |
++ |
+++ |
++ |
+++ |
++ |
+++ |
++ |
+++ |
++ |
10 |
Protein (Biuret) |
+++ |
++ |
+ |
+ |
- - - |
- - - |
- - - |
- - - |
- - - |
- - - |
- - - |
- - - |
11 |
Proteins (Millions) |
+ |
+ |
- - - |
- - - |
- - - |
- - - |
- - - |
- - - |
- - - |
- - - |
- - - |
- - - |
12 |
Reducing Carbohydrate (Benedicts) |
- - - |
- - - |
- - - |
- - - |
- - - |
- - - |
+++ |
+++ |
+++ |
+++ |
+++ |
+++ |
13 |
Cardiac glycosides |
- - - |
- - - |
- - |
- - |
- - |
- - |
- - |
- - |
- - |
- - |
- - |
- - |
14 |
Glycosides -cardiac active aglycones (Legal) |
+++ |
+++ |
+++ |
+++ |
+++ |
+++ |
+++ |
+++ |
+++ |
+++ |
+++ |
+++ |
+++ Maximum
presence; ++ Moderate presence; +
Minimum presence; - - - Nil
Phytochemical analysis:
These studies were performed
according to the standard methods9. The aqueous and organic extracts
were subjected to preliminary phytochemical characterization, which revealed
the presence of the phytochemicals-alkaloids,
phenols, flavonoids, sterol, saponin
glycosides, reducing sugars, proteins, cardio active aglycones
and cardinolides, saponin
glycosides.
Antimitotic
activity:
A. cepa was
sprouted in tap water for 48 hours at room temperature. The bulbs that
developed uniform root were used for the experiment. These roots were treated
with above prepared extracts of 10 concentrations. Water was used as
medium/vehicle dilution. The different fractions used have been mentioned in
Table 1. A blank with water was used as control. Methotrexate
was used as a standard control. After 3hours of treatment, the root tips were
fixed with fixing solution of acetic acid and alcohol. Squash preparations were
made by staining the treated roots with acetocarmine
stain and observed. The mitotic index was calculated as
Mitotic Index = Number of
dividing cells/Total number of cells x 100
Folic acid added
to the solution of methotrexate, aqueous extract and
organic extract of Brassica oleracea.
A similar experiment was undertaken to find out the probable mechanism of
action through which the extracts and methotrexate
act. Squash preparations made as above from the treated roots were observed.
Separation
of sterols by thin layer chromatography:
Slurry of silica gel GF254 was
made with distilled water. This slurry was then applied on glass plates (12.5 x
12.5cm) with the aid of a TLC spreader to obtain preparative silica gel plates
having thickness of about 0.5mm. The plates were dried in an oven at 105oC
and activated 2hrs before use.
Extraction
of sterol from sample:
Three gms of
floret and stem of Brassica oleracea were
homogenized and extracted with extraction solvent [either ethyl ether: ethanol
(3:1) or chloroform: methanol (2:1)]. The contents were mixed vigorously and
allowed to stand till the two phases were completely separated. The lower
organic layer was drained out, which contained the sterol. The solvents were
evaporated. Concentrated extracts were spotted on the plate. The plates were
developed in the solvent system consisting of petroleum ether or hexane: ethyl
ether: glacial acetic acid (80: 20: 5) till the solvent travelled up to 1 cm
from the opposite side of the plate. the plate were allowed to air dry 50% sulphuric acid was
sprayed and heated in an oven at 110 บ C for 10 min. The plates were visualized
and the spots were marked. Then the results were compared with standard sterol.
Plate: 1 Treatment of Allium
cepa roots with different extract of Brassica oleracea and solutions
1. Standard Methotrexate, 2. Methotrexate +
Folic acid, 3. Water, 4. Ice cold water (floret), 5. Icecold
water(stem), 6.Aqueous(floret), 7. Aqueous (Stem), 8. Methanol(floret), 9.
Methanol(stem), 10. Chloroform (florate), 11.
Aqueous(florate) + Folic acid, 12. Aqueous(florate) + Folic acid, 13. Methanol (florate)
+ , 14. Methanol(stem)+ Folic acid, 15. Chloroform (florate)+
Folic acid, 16. Ice cold water (floret) + Folic acid
RESULTS AND DISCUSSION:
The results and discussion were discussed
under two phases.
Phase
I : Phytochemical analysis
Phase
II : Antimitotic activity
Phase
I:
The aqueous and organic extracts of Brassica oleracea were
subjected to preliminary Phytochemical characterization, which revealed the
presence of many phytochemicals-alkaloids,
phenols, flavonoids, sterol, saponin
glycosides, reducing sugars, proteins, cardio active aglycones
and cardinolides. The most important property of this
phytochemicals is antimitotic
activity.Saponins are found to have numerous health
benefits. They lyse blood cells. Recent studies have
illustrated saponins effects which have been
beneficial on the control of blood cholesterol levels, bone health, cancer, and
building up of the immune system. Saponin stromatolytic solution is being used for treating malaria.10
The most important advantage of using saponin
is that it is completely renewable, biodegradable material which can be put on
to the compost heap once it gets spent. Saponins are
allergy free and are especially beneficial for babies and children who have
sensitive skin. People suffering from allergies and dermatitis will be
benefited by using liquid soap solution prepared from saponin11.
Anticancer activity has been reported for a
number of triterpene and steroid saponins12,13,14.
Steroid saponin-containing plant materials gained
commercial significance in 1950s as raw materials for the production of
steroid hormones and drugs. The synthesis of progesterone from the sapogenin diosgenin obtained from
Mexican Yam by Marker et al. in
1940s15was the beginning of a remarkable era in steroid research
culminating in the synthesis of the first oral contraceptive in 1951.
Saponins have been used as immunological adjuvants
in veterinary vaccine formulations due to their immune enhancing properties
since 1950s16. The wealth of information on the biological activity
of saponins and aglycones
from a variety of sources is providing leads for the development of drugs. The
chemo preventive and chemotherapeutic activities of ginseng dammarane
sapogenins have prompted the development of
anticancer drugs for the various stages of development of cancer17.
Pharmaceutical compositions or plant extracts
containing saponins have been patented for the
prevention and treatment of a variety of conditions such as inflammation, infection18,
alcoholism pre- and post-
menopausal symptoms19, cardiovascular and cerebrovascular
diseases such as coronary heart disease and hypertension20,21,
prophylaxis, dementia22, ultraviolet damage including cataract, and
carcinoma cutaneum23, gastritis, gastric ulcer, and duodenal ulcer24.
The use of saponins in pharmaceutical preparations as
adjuvants to enhance absorption of pharmacologically
active substances or drugs has also been patented25,26.
Flavonoids are polyphenolic
compounds that are ubiquitous in nature. The flavonoids have aroused considerable interest recently
because of their potential beneficial effects on human health, they have been
reported to have antiviral, anti-allergic, antiplatelet,
anti-inflammatory, antitumor and antioxidant activities, heart disease, asthma
and stroke. They may also play a special role in protecting the brain.
Flavonoids are another large family of protective phytochemicals found in fruits and vegetables. Flavonoids, also called bioflavonoids,
act as antioxidants. Antioxidants neutralize or inactivate highly unstable and
extremely reactive molecules, called free radicals that attack the cells of our
body every day. Free radical damage is believed to contribute to a variety of
health problems, including cancer, heart disease and aging27-29.
Phenolic compounds may reduce the risk of heart
disease and certain types of cancer. Indoles may reduce the risk of certain types of
cancer, including breast cancer. Indoles are found in
cruciferous vegetables, such as broccoli30-32.
Phase II: Antimitotic
activity:
Antimitotic activities of the aqueous and organic extracts were
comparable to the activity of methotrexate. The aqueous extract showed lowest mitotic
index with highest activity among all the different fractionated extracts.. The
phases were differentiated in each case and it was observed that the number of
non-dividing cells increased in extract treated root tips than with folic acid
added extracts.
The cell divisions were differentiated and the numbers
of cells in each phase of cell division i.e. either prophase, metphase, anaphase, or telophases
were recorded.
Plate: 2
Plate 2 showed that the mitotic activity was quiet high
when treated with water alone. The numbers of dividing cells were high as there
is no antimitotic principle in water. Hence it was
considered as control
Plate-3
Plate 3a Plate
3b
Plate 3 Antimiotic
activity of methotrexate, methotrexate
+ folic acid and the stages of cell division
Plate 4a
Plate 4b
Plate-4 : Antimitotic
activity of ice cold floret, floret + folic acid extracts of Brassica oleracea and the stages of cell division
Plate 5b
Plate 5: Antimiotic
activity of ice cold water stem, ice cold water stem + folic acid extract of Brassica oleracea and
the stages of cell division
Plate 6a
Plate 6b
Plate 6: Antimitotic
activity of aqueous floret, aqueous floret + folic acie
extracts of Brassica oleracea and
the stages of cell division
Plate 7a
Plate 7b
Plate 7: Antimitotic
activity of aqueous stem, aqueous stem+folic acid extracts
of Brassica oleracea and
the stages of cell division
Plate 8a
Plate 8b
Plate 8: Antimitotic
activity of methanol floret, methanol floret + folic acid extracts of Brassica oleracea and the stages
of cell division
Plate 9a
Plate 9b
Plate 9: Antimitotic
actifity of methanol stem, methanol stem + folic acid
extracts of Brassica oleracea
and the stages of cell division
Plate 3a showed that the mitotic activity was almost
nil when the A.cepa
root tips were treated with methotrexate. Maximum
numbers of non-dividing cells were observed. Methotrexate-anticancer
drug which competitively inhibits dihydrofolate reductase (DHFR), an enzyme that
participates in the tetrahydrofolate synthesis. Methotrexate acts specifically during DNA and RNA synthesis,
and thus it is cytotoxic during the S-phase of the cell cycle.
Logically, it therefore has a greater toxic effect on rapidly dividing cells
such as malignant and myeloid cells33,34.
Plate 3b showed that methotrexate
+ folic acid treated cells increased the mitotic activity to a certain extent.
Folic acid is essential for the production of tertrahydrofolic
acid (THF) which in turn required for synthesis of DNA and consequently for
cell replication. Hence the dividing cells were high compared to that of the methotrexate treated cell35.
10a
10b
Plate 10: Antimitotic
activity of chloroform floret, chloroform floret + folic acid extracts of Brassica
oleracea and the stages of cell division.
11a
11b
Plate 11: Antimitotic
activity of chloroform stem, chloroform stem + folic acid extracts of Brassica
oleracea and the stages of cell division.
Plate-4
Plate 4 showed that the number of non-dividing cells
were in the following order.
Ice cold water floret extract > Ice cold water
floret extract +folic acid > water
Plate 5
Plate 5 showed that the number of non-dividing cells
were in the following order.
Ice cold water stem extract > Ice cold water stem
extract +folic acid > water
Plate 6
Plate 6 showed that the number of non-dividing cells
were in the following order.
Aqueous floret extract > Aqueous floret extract +
folic acid > Water
Plate 7 Plate 7 showed that the number of
non-dividing cells were in the following order.
Aqueous stem extract > Aqueous stem extract + folic
acid > Water
Plate 8
Plate 8 showed that the number of non-dividing cells
were in the following order.
Methanol floret extract > Methanol floret extract +
folic acid > Water
Plate 9
Plate 9 showed that the number of non-dividing cells
were in the following order.
Methanol stem extract > Methanol stem extract +
folic acid > Water
Plate 10
Plate 10 showed that the number of non-dividing cells
were in the following order.
Chloroform floret extract > Chloroform floret
extract + folic acid > Water
Plate 11
Plate 11 showed that the number of non-dividing cells
were in the following order.
Chloroform stem extract > Chloroform stem extract +
folic acid > Water
Table 2: Antimitotic
activity after treatment of Allium cepa root with aqueous, organic extract of Brassica oleracea, methotrexate and aqueous extract+folic
acid, organic extract+folic acid, methotrexate+folic
acid
S. No. |
Different
solutions used for treatment |
% of
non-dividing cells |
% of
dividing cells |
Mitotic index |
Mitotic Index |
|||||
P |
M |
A |
T |
|
Mean |
SD |
SEM |
|||
1 |
Methotrexate |
77 |
22 |
- |
- |
- |
22 |
|
|
|
2 |
Methotrexate+Folic acid |
30 |
68 |
- |
- |
1 |
69 |
68.5 |
0.92 |
0.53 |
3 |
Water |
14 |
20 |
22 |
19 |
24 |
85 |
85.7 |
0.17 |
0.09 |
4 |
Ice cold water
(Floret) |
47 |
15 |
10 |
13 |
13 |
52 |
52.4 |
0.75 |
0.43 |
5 |
Ice cold
water(Stem) |
41 |
25 |
8 |
11 |
13 |
58 |
58.3 |
0.57 |
0.32 |
6 |
Aqueous(Floret) |
39 |
19 |
13 |
11 |
15 |
59 |
60.5 |
0.86 |
0.49 |
7 |
Aqueous(Stem) |
28 |
22 |
24 |
7 |
16 |
71 |
71.1 |
0.28 |
0.16 |
8 |
Methanol(Floret) |
41 |
16 |
12 |
12 |
16 |
57 |
58 |
0.63 |
0.36 |
9 |
Methanol(Stem) |
33 |
25 |
14 |
8 |
17 |
65 |
66.1 |
0.40 |
0.23 |
10 |
Chloroform(Floret) |
33 |
25 |
13 |
12 |
16 |
66 |
66.7 |
0.23 |
0.13 |
11 |
Aqueous(Floret)+Folic
acid |
18 |
31 |
21 |
18 |
10 |
81 |
81.5 |
0.05 |
0.02 |
12 |
Aqueous(Stem)+Folic
acid |
15 |
28 |
26 |
10 |
20 |
84 |
84.6 |
0.34 |
0.19 |
13 |
Methanol(Floret)+Folic
acid |
15 |
40 |
15 |
12 |
15 |
84 |
84.4 |
0.11 |
0.06 |
14 |
Methanol(Stem)+Folic
acid |
14 |
20 |
25 |
14 |
25 |
85 |
85.6 |
0.17 |
0.09 |
15 |
Chloroform(Floret)+Folic
acid |
11 |
32 |
17 |
18 |
19 |
88 |
88.4 |
0.23 |
0.13 |
16 |
Cold
water(Floret)+Folic acid |
17 |
28 |
16 |
17 |
19 |
82 |
82.1 |
0.17 |
0.09 |
Effect of folic acid on antimitotic
activity of Brassica oleracea and methotrexate:
Analysis of data using a
3-way ANOVA showed that there was a significant effect of the pretreatment with
folic acid on the antimitotic activity of Brassica
oleracea and methotrexate.
The mitotic index increased when folic acid was added to the extracts of Brassica oleracea and methotrexate
solution which otherwise reduce the mitotic activity in the absence of folic
acid. This however, did not increase with increase in folic acid concentration
suggesting that the effect was not dose-dependent. Comparing the mitotic index
of methotrexate and Brassica oleracea extracts, it was observed that incorporation of folic
acid increased the mitotic index significantly in case of methotrexate,
but not so in case of Brassica oleracea. Post-hoc analysis of the data showed that folic acid inhibited the
anti-mitotic activity of methotrexate to a greater
extent as compared to Brassica oleracea. Results from our study indicate that ice cold water extract of Brassica oleracea had
excellent antimitotic activity that was comparable to
the activity of methotrexate. Addition of folic acid
inhibited the antimitotic activity of Brassica oleracea significantly but not completely. Thus,
it may be hypothesized that the extract may be acting through the pathway
inhibiting tetrahydrofolic acid and hence folic acid
required for DNA synthesis that arrests cell division. Methotrexate
is a known anticancer drug which competes with folic acid for the enzyme reductase. The total aqueous extracts of Brassica oleracea may also
be competing with folic acid thus inhibit the DNA synthesis. Hence, addition of
folic acid increases the mitotic index due to the availability of folic acid.
However, the mitotic index does not increase significantly in case of Brassica oleracea as
compared to that of methotrexate because the extract
may be mediating its effects through other mechanisms also. The phytochemicals present in the extract may bind with
different cell proteins which are responsible for cell division.
Cancer usually evolves over a long period of time,
agents that inhibit or retard one or more of its stages could affect the
overall course of the disease. Certain micronutrients like polyphenolic
compound posses potent cancer-preventive abilities. The blocking and
suppressing agents found in specific herbs and food are having anticancer
activities. These compounds inhibit cancer formation by blocking or diverting
carcinogenic material away from the cell, allowing it to be metabolized by the
liver to a less toxic and more excretable substance.
This may prevent cancerous substance reacting with the cells
DNA before it can do any damage and hence its excretion through metabolism.
This may retard cancer promotion by decreasing or turning off promotional
factors that would otherwise be used for cancer promotion and proliferation.
One of the most important effects of blocking agents found in herbs and foods
in the inhibition of tumor formation by curbing the arachidonic
acid cascade. This effect is particularly evident in high quality fats. Herbs
that contain antitumour alkaloids can directly
inhibit cancer growth because of their inhibitory activity against reverse
transcriptase of RNA tumour viruses. This mechanism
of action occurs within the cell cycle process. A more direct antitumour mechanism of plant compound has to do with
inhibiting tubulin polymerization. This is the way
that most chemotherapies work. These antitumour
compounds are called antimitotic agents36.
CONCLUSION:
From this study, it could be suggested that Brassica oleracea have
been shown to posses cancer chemo preventive effects within their diverse
pharmacological properties. Phytochemical characterization revealed the
presence of many phytochemicals-alkaloids, phenols, flavonoids, sterol, saponin
glycosides, reducing sugars, proteins, cardio active aglycones
and cardinolides. The results obtained from the
present study pinpoint that antimitotic activity of Brassica oleracea may
be due to the presence of flavonoids, steroids,
alkaloids, polyphenols and saponins.
Mechanism of action of herbs that contains these phytochemicals
occurs with in the cell cycle process. Hence these
anti tumour compounds are called antimitotic
agents. Brassica oleracea showed
commendable antimitotic activity which can be exploided as cancer therapy.
REFERENCES:
1.
Abhang R Y. Jogiekar P P and Kulkarni P H, Preliminary study on the effect of T.cordifolia ,on mitosis, Ancient Sci, (1991)1.27.
2.
Baton
Rouge, LA. Broccoli. USDA, NRCS.. The PLANTS Database
(http://plants.usda.gov). National Plant Data Center, (2008)70874-4490 USA.
3.
Bombardelli, E. and Gabetta,
B. Soya extract, process for its preparation and pharmaceutical
composition. US Patent (2001),6,280,777.
4.
Broccoli. Merriam-Webster's Collegiate Dictionary
(2009)(11th ed.). p. 156. ISBN 9780877798095.
http://www.merriam-webster.com/dictionary/broccoli. Retrieved 24 August.
5.
Brown, M. D. Altern. Med Rev.
4, (1999) 360 370
6.
Bushman, J. L. Nutr. Cancer (1998) 31, 151159
7.
Dalsgaard, K. Saponin adjuvants. 3. Isolation
of a substance from Quillaja saponaria
Molina with adjuvant activity in food-andmouth
disease vaccines. Arch Gesamte Virusforsch(1974)
44, 243254.
8.
Donald R. Yance, Jr., C.N.,M.H.,A.H.G.,et.al
Herbal Medicine, Healing and Cancer- A
Comprehensive Program for Prevention and
Treatment .
9.
Dutta A C, A text book of botany,( 1971) edition 14(Indian branch of Oxford
University Press),29.
10.
Ferguson L R, Role of plant polyphenols
in genomic stability, Mut Res,475(2001),89.
11.
Finley JW., Reduction of cancer risk by consumption
of selenium-enriched plants: enrichment of broccoli with selenium increases the
anticarcinogenic properties of broccoli. J Med Food .; (2003)6(1):19-26.
12.
Forse, R. A. and Chavali, S. Enternal formulations for treatment of inflammation and
infection. US Patent (1997),5,674,853.
13.
Hidvegi,
M. Process for the preparation of a
pharmaceutical composition selectively lowering the blood-lipid level. US
(1994),5,277,910. .
14.
http://www.phytochemicals.info/plants/broccoli.php
15.
http://www.whfoods.com/genpage.php?tname=foodspiceanddbid=9.
16.
Jeffery EH, Keck AS., Translating knowledge generated
by epidemiological and in vitro studies into dietary cancer prevention. Mol Nutr Food Res
.; (2008)52(suppl 1):S7-S17
17.
John Heinerman ,Heinerman's Encyclopedia Of Fruits, Vegetables and
Herbs (1988)
18.
Johnston, Andrew; Gudjonsson, Johann Eli; Sigmundsdottir,
Hekla; Runar Ludviksson, Bj๖rn; Valdimarsson, Helgi. "The anti-inflammatory action of methotrexate is not mediated by lymphocyte apoptosis, but
by the suppression of activation and adhesion molecules". Clinical
Immunology (2005)114 (2):
15463.
19.
Kensil, C. A., Soltysik, S., Marciani, D. J. and Recchia,
J. Drug delivery enhancement via modified saponins.WO
Patent(1996)/38161.
20.
Kim, D. H., Bae, E. A., Han, M. J., Choo,
M. K., Park, E. K. and Park, J. H. Novel use of the extract
of processed panax genus plant and saponin compound isolated there from. US Patent Application
(2003)/0190377 A1.
21.
Kimata, H., Sumida, N., Matsufuji,
N., Morita, T., Ito, K., Yata,
N. and Tanaka, O. Interaction of saponin
ofBupleuri Radix with ginseng saponin: solubilization of saikosaponin-a with chikusetsu-saponin
V (= ginsenoside-Ro).Chem. Pharm. Bull.,
(1985),33: 28492853. [PubMed], [Web of Science ฎ]
22.
Latha P G, Chandralekha C T, Vilasini G and Panikkar K R, Effects of the flower extract of lxora coccines linn. On the meristametic cells
of A.cepa, Ancient Science of Life,
(1998)17/4262.
23.
M.A. Ponce, J.M. Scervio,
R. Erra-Basells, J.A. campo, A.M. Godeas,
Phytochemistry (2004) 65 31313134.
24.
Ma, B., Dong,
J. and Wang, B. Use of steroidal saponins
for the propylaxis or treatment of dementia, and
novel steroidal saponin compounds. US
Patent(2003), 6,593,301.
25.
Marker, R. E., Wagner, R. B., Ulshafer,
P. R. Wittbecker, E. L., Goldsmith, D. P. J. and Ruof, C. H.. J. Amer.chem. Soc.
(1947)69, 2167.
26.
Mukhtar, H., and Ahmad, N. Am. J. Clin. Nutr.
(2000) 71, 1698S1702S
27.
Paech, D and Tracey,M.V.Modern methods of plant analysis. Ed
iv.(1955),373-374.
28.
Panagin Pharmaceuticals Inc. http://www.panagin.com/ index.htm accessed(2005).
29.
Paul, H. W. Clio
Med. (2001) 64, 269 304
30.
Rajagopalan, P. T. Ravi; Zhang, Zhiquan;
McCourt, Lynn; Dwyer, Mary; Benkovic, Stephen J.; Hammes, Gordon G. "Interaction of dihydrofolate
reductase with methotrexate:
Ensemble and single-molecule kinetics". Proceedings of the
National Academy of Sciences (2002). 99. (21): 134816.
31.
Satoshi, M., Erihi, O. and Satariyo,
G. Composition for preventing or ameliorating ultraviolet damage. JP
Patent (2004),131,431.
32.
Satoskar R S and Bhandarkar S D., Pharmacology
and pharmacotherapeutics,(1989) Vol.2, edition 11(Popular Prakashnan, Bombay),704.
33.
Wallach, J.D. and Ma Lan, M.D., Let's Play Herbal Doctor , Wellness
Publications, LLC, Bonita , CA , (2002).
34.
Williams G O and O moh L E,
Mitotic effects of aqueous leaf extract of Cymbopogo citrates in Allium
cepa root tips, Cytobios, (1996)87, 161.
35.
www.wikipedia.com
36.
Yao, X., Li,
L. and Wang, N. New use of saponin compound
for treating cardiovascular disease. CN Patent (2005),1,562,064.
Received on 24.12.2011 Accepted on 10.02.2012
ฉ Asian Pharma
Press All Right Reserved
Asian J. Pharm.
Res. 2(1): Jan.-Mar. 2012;
Page 19-31